标题
Update on adjuvant therapy in completely resected
NSCLC patients
作者
关键词
-
出版物
Thoracic Cancer
Volume 13, Issue 3, Pages 277-283
出版商
Wiley
发表日期
2021-12-13
DOI
10.1111/1759-7714.14277
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
- (2021) Fangqiu Fu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase II, open-label, single-arm, multicenter study to assess the activity and safety of alectinib as neoadjuvant treatment in surgically resectable stage III ALK-positive NSCLC: ALNEO trial
- (2021) Leonetti Alessandro et al. Clinical Lung Cancer
- The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures
- (2021) Tao Shi et al. Frontiers in Oncology
- Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
- (2021) Justin M. Burgener et al. CLINICAL CANCER RESEARCH
- IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).
- (2021) Heather A. Wakelee et al. JOURNAL OF CLINICAL ONCOLOGY
- The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study
- (2021) Tomo Sato et al. LUNG CANCER
- Neoantigen load as a prognostic and predictive marker for stage II / III non‐small cell lung cancer in Chinese patients
- (2021) Lei Gong et al. Thoracic Cancer
- Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy
- (2021) Zhouguang Hui et al. JAMA Oncology
- Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study
- (2021) Abdul Rahman Jazieh et al. Journal of Thoracic Oncology
- Prognostic impact of PD-L1 expression in correlation with neutrophil-to-lymphocyte ratio in squamous cell carcinoma of the lung
- (2020) Yuko Tashima et al. Scientific Reports
- Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
- (2020) Yu-Tao Liu et al. Cancer Management and Research
- LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683
- (2020) C. Le Pechoux et al. ANNALS OF ONCOLOGY
- Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
- (2020) Yi-Long Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
- (2020) Muyun Peng et al. Frontiers in Oncology
- Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non–small-cell Lung Cancer
- (2019) Masaki Nakamura et al. Clinical Lung Cancer
- Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging
- (2019) Johannes R. Kratz et al. Journal of Thoracic Oncology
- Prognostic impact of the number of metastatic lymph nodes on the eighth edition of the TNM classification of non-small cell lung cancer
- (2019) Shinya Katsumata et al. Journal of Thoracic Oncology
- Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
- (2019) Thomas Muley et al. LUNG CANCER
- Current status of immune checkpoint inhibition in early-stage NSCLC
- (2019) J Vansteenkiste et al. ANNALS OF ONCOLOGY
- c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
- (2019) Georgios Tsakonas et al. LUNG CANCER
- Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non–Small-Cell Lung Cancer
- (2018) Samual Francis et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR -mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
- (2018) Wen-Zhao Zhong et al. LANCET ONCOLOGY
- Anaplastic lymphoma kinase rearrangement in surgically resected stage IA lung adenocarcinoma
- (2018) Sun Hye Shin et al. Journal of Thoracic Disease
- Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting a treatment outcomes of non–small cell lung cancer
- (2018) Juliana Machado-Rugolo et al. HUMAN PATHOLOGY
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
- (2018) Dongsheng Yue et al. Lancet Respiratory Medicine
- Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
- (2018) Yang Xie et al. CLINICAL CANCER RESEARCH
- The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer
- (2018) Chongze Yuan et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
- (2018) Jyothi Thyagabhavan Mony et al. Frontiers in Immunology
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- Factors predicting organ-specific distant metastasis in patients with completely resected lung adenocarcinoma
- (2016) Jung-Jyh Hung et al. Oncotarget
- Impact of Adjuvant Treatment for Microscopic Residual Disease After Non-Small Cell Lung Cancer Surgery
- (2015) Jacquelyn G. Hancock et al. ANNALS OF THORACIC SURGERY
- Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
- (2013) Liang Zhang et al. Thoracic Cancer
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
- (2012) Johannes R Kratz et al. LANCET
- Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial
- (2010) Noriyasu Usami et al. International Journal of Clinical Oncology
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
- (2009) Rodrigo Arriagada et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started